We have heard from our clients and others in the dental community that
supply and lab companies are raising their rates at least 2.3% across the board
due to the new medical device excise tax. This across the board raise may be nothing
more than a move to use this new tax as an excuse to pad their profits. We are suggesting
that dentists who receive such a notice to challenge these companies and ask
them to furnish the FDA list of those products that are subject to this excise
tax to verify their claim that they are subject to the tax.
For more information, please contact info@dentalcpas.com
Follow us on Twitter, Facebook and Pinterest – sign up for our newsletter
No comments:
Post a Comment